Trial Profile
Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L) in Patients with Advanced Malignancies.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2014
Price :
$35
*
At a glance
- Drugs Curcumin (Primary) ; Curcumin (Primary) ; Resveratrol
- Indications Cancer
- Focus Adverse reactions; Pharmacokinetics
- 16 Jan 2014 Status changed from active, no longer recruiting to discontinued; according to M.D. Anderson Cancer Center record.
- 26 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Apr 2012 Status changed from active, no longer recruiting to recruiting as reported by M.D. Anderson Cancer Center record.